← Back to Search

Core Exercise Promotion Intervention for Breast Cancer

N/A
Waitlist Available
Led By Courtney J Stevens, PhD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-weeks follow-up assessment
Awards & highlights

Study Summary

This study is evaluating whether an exercise prescription can be refined for use with survivors of breast cancer.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-weeks follow-up assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-weeks follow-up assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of the Affect-regulated Exercise Prescription Measured Using the Treatment Acceptability and Preferences (TAP) Measure
Number of Participants Who Completed the Exit Interview
Percentage of Ecological Momentary Assessment (EMA) Survey Prompt Completion
+4 more
Secondary outcome measures
Average Minutes of Daily Moderate-vigorous Physical Activity Measured Using the ActiGraph wGT3X-BT Accelerometer at 12 Weeks Follow-up
Satisfaction With Study Participation as Measured by the Participant Satisfaction Questionnaire
Study Retention at 12-weeks Follow-up
+2 more
Other outcome measures
Average Minutes of Daily Moderate-vigorous Physical Activity Measured Using The Godin Leisure-Time Exercise Questionnaire at 12 Weeks Follow up
Average Minutes of Daily Moderate-vigorous Physical Activity Measured Using The Godin Leisure-Time Exercise Questionnaire at 2 Weeks Follow up
Average Minutes of Daily Moderate-vigorous Physical Activity Measured Using The Godin Leisure-Time Exercise Questionnaire at 6 Weeks Follow up
+12 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Affect-regulated exercise prescriptionExperimental Treatment1 Intervention
Participants receive instructions to adjust their pace of exercise so that they feel "fairly good" or better (i.e., a rating of +1 or higher on the Feeling Scale) while exercising and to avoid any increases in intensity that promote feeling "fairly bad" or worse. If no intensity of exercise feels at least "fairly good" participants will be told to exercise at an intensity that feels "as positive as possible."
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Core Exercise Promotion Intervention
2021
N/A
~40

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,543,302 Total Patients Enrolled
28 Trials studying Breast Cancer
2,352,793 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,664 Previous Clinical Trials
40,926,096 Total Patients Enrolled
939 Trials studying Breast Cancer
1,543,323 Patients Enrolled for Breast Cancer
Courtney J Stevens, PhDPrincipal InvestigatorDartmouth-Hitchcock Medical Center
2 Previous Clinical Trials
115 Total Patients Enrolled
2 Trials studying Breast Cancer
115 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation
Courtney J. Stevens 2021. "A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04903249.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top